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Abstract
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), linked with
CRISPR associated (CAS) genes, play a profound role in the interactions between
phage and their bacterial hosts. It is now well understood that CRISPR-CAS sys-
tems can confer adaptive immunity against bacteriophage infections. However, the
possibility of failure of CRISPR immunity may lead to a productive infection by the
phage (cell lysis) or lysogeny. Recently, CRISPR-CAS genes have been implicated
in changes to group behaviour, including biofilm formation, of the bacterium Pseu-
domonas aeruginosa when lysogenized. For lysogens with a CRISPR system, another
recent experimental study suggests that bacteriophage re-infection of previously lyso-
genized bacteria may lead to cell death. Thus CRISPR immunity can have complex
effects on phage-host-lysogen interactions, particularly in a biofilm. In this contri-
bution, we develop and analyse a series of models to elucidate and disentangle these
interactions. From a therapeutic standpoint, CRISPR immunity increases biofilm re-
sistance to phage therapy. Our models predict that lysogens may be able to displace
CRISPR-immune bacteria in a biofilm, and thus suggest strategies to eliminate phage-
resistant biofilms.
Keywords: Bacteria, Bacteriophage, Biofilm, CRISPR-CAS system, Lysogens.
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Table 1: NOMENCLATURE
Parameters Description Dimensions
H Density of wild-type (non-lysogenic) bacteria cells cm−2
HL Density of lysogens cells cm
−2
CS Density of bacteria with CRISPR-immunity/spacer cells cm
−2
CL Density of lysogens with CRISPR system cells cm
−2
V Density of phage phage cm−2
t Time hr
K Carrying capacity of bacteria in biofilm cells cm−2
α Prophage induction hr−1
r Bacterial growth rate hr−1
b Burst size phage cell−1
β Adsorption rate cm2 phage−1 hr−1
γ Phage loss rate hr−1
θ Adhesion rate per cell hr−1
η Slouging off rate of non-lysogens hr−1
ηL Sloughing off rate of lysogens hr
−1
φ Planktonic bacteria forming biofilm cells cm−2 hr−1
pL Probability of lysogenization −
pF Probability of CRISPR failure −
pD Probability of cell death −
3
1 Introduction
The co-existence of bacteria and bacteriophage has been of prolonged interest to evolutionary
biologists [1]. Temperate phage are of particular interest as these viruses can reproduce
either through the lytic cycle, causing bacterial cell death, or the lysogenic cycle, allowing
both phage and host to survive [2, 7, 18, 56]. An important factor in this co-existence is a
mechanism known as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
that not only provides adaptive immunity against viral infections but also helps to protect
the bacterial genome from foreign mobile elements such as phage and plasmids [11, 50].
The building blocks of CRISPR systems were first identified thirty years ago, when inter-
spaced DNA repeats were found in specific regions of the E. coli genome [30]. Research
efforts quantified the variation in these sequences, their lengths and positions, in bacterial
and archaea genomes [5, 9, 39] before the name CRISPR was first applied [31]. CRISPR
systems have now been identified in nearly 45% of bacterial strains and have been classified
into three types that are further divided according to the phylogeny of the CRISPR sequences
and their CRISPR-associated (CAS) genes [11]. Moreover, multiple CRISPR-CAS systems
exist in several bacterial strains demonstrating that different types are compatible with each
other within a single cell [16, 57].
The CRISPR adaptive defense mechanism proceeds in three main steps [11]. Firstly, the
CRISPR-CAS system requires a specific sequence in phage DNA known as the protospacer
that is acquired as a spacer into a designated position in the bacterial genome known as the
CRISPR-locus, which lies next to the CAS genes [8, 22]. This acquisition is made possible
by means of a short conserved sequence, present in the vicinity of protospacers, known as the
protospacer adjecent motif (PAM) [17, 42]. CRISPR-loci have the capacity to store hundreds
of spacers in the form of an array, while each spacer in the array is surrounded by short
palindromic repeats known as CRISPR-repeats [34]. In the second step, the CRISPR-locus
is transcribed and expressed as a single long mRNA that is cleaved into a single spacer and
partial repeat known as CRISPR-RNA (crRNA) [24]. Depending upon the type of CRISPR
system [11, 46], crRNA is associated with a CAS protein which provides a strong response
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against any RNA/DNA sequences matching the protospacer and begins to cleave these viral
sequences with the help of CAS enzymes; this third step is known as interference. In the
case of subsequent infections by the same type of phage, the crRNA associated with the CAS
protein promptly responds and cleaves the phage genome. However, the presence of a limited
number of crRNA/CAS complexes inside the cell can lead to CRISPR failure in the case of
multiple simultaneous viral infections. Moreover, small variations in PAM can also lead to
immune failure resulting in phage infection. In addition, rapidly mutating phage can escape
this bacterial immunity by varying the protospacer or PAM sequences. A balance between
phage diversification and CRISPR immunity can result in a stable co-existing community
[4, 28, 53].
Biofilm formation is another protective mechanism used by bacterial colonies. For example,
P. aeruginosa preferentially exhibits an anaerobic biofilm mode of growth at human body
temperature [54, 58]. In particular, when this pathogen colonizes wound infections (e.g.
suppurative or purulent bacterial infections) or the lungs of cystic fibrosis patients [15, 48],
it forms micro-colony structures which exhibit extremely high levels of antibiotic resistance
[15]. Bacterial cells undergo profound phenotypic changes during the transition from free-
floating planktonic to biofilm-associated cells [43].
New advancements in phage therapies are considered to be a promising way to eradicate
some otherwise untreatable bacterial infections [41, 45]. Although the therapeutic effect of a
virulent phage is typically more effective than a temperate phage [49], virulent phage therapy
is not always possible and therefore the use of temperate phage is sometimes inevitable
[12, 44, 47]. In particular, nearly 100% lysogenization can be achieved for P. aeruginosa when
exposed to some viruses, [36], but these lysogens are normally immune to super-infection and
plaque formation by the same phage [55].
Recent studies have revealed an effect of the type-I CRISPR-CAS system on the regulation
of group behaviours in one strain of P. aeruginosa, PA14 [29, 59]. In particular, it has
been demonstrated that PA14 is unable to form biofilm and loses swarming motility when
CRISPR-CAS identifies a specific protospacer and PAM in a prophage sequence in the bac-
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terial genome [29]. This result demonstrates that the CRISPR-CAS system, in addition to
its role as an adaptive immune response, can regulate the genomic content of bacteria and
help protect bacterial colonies from lysogenization; in fact, very few prophage are observed
in P. aeruginosa genomes that carry CRISPR systems [19, 37]. The regulation of bacterial
genomic content by means of the CRISPR-CAS system has been found in other bacterial
strains as well, in which not only is lysogeny prevented, but also existing prophage is tar-
geted, typically resulting in cell death due to genomic breakdown [19]. This self-destruction
of lysogens may protect colonies by reducing the chance of prophage induction.
The effects of CRISPR-CAS systems on bacteria-phage interactions have been studied the-
oretically using a range of mathematical modelling approaches [14, 23, 26, 27, 35]. To date,
these models have been developed for virulent phage assuming that CRISPR systems func-
tion as adaptive immune systems, without affecting other cellular processes such as biofilm
formation [29, 59] or the cleavage of prophage [19]. In parallel with these efforts, a number
of models have been developed to study the ecological effects of bacterial group behaviours,
particularly biofilm formation [6, 10, 20, 21, 33, 40]. Modelling efforts directed toward phage
infection in biofilms are relatively rare [1, 51].
The goal of this work is to investigate the effects of a temperate phage infection in a bacterial
biofilm. Our approach is to develop a series of models that help to isolate and disentangle
the roles of bacterial hosts, either with or without a CRISPR system, lysogens, and phage.
Not surprisingly, our models predict that CRISPR-immune bacteria in a biofilm, such as P.
aeruginosa in cystic fibrosis, will be difficult to eradicate by phage therapy. However our
results suggest that lysogens without a functioning CRISPR system may in some parameter
regimes be able to invade and dominate the biofilm, offering a possible avenue for therapy.
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2 Model
2.1 Model Formulation
We develop a series of three models to investigate the effect of infection by temperate phage
on a bacterial biofilm, for a host species either with or without a CRISPR-CAS system.
Motivated by predominantly single species biofilms as seen in P. aeruginosa [29], all of the
models consider cells of a single bacterial species within a biofilm. Each model has two
bacterial populations and a population of bacteriophage as described in the Figure 1. In the
first model, the population dynamics of host cells, H , lysogenized host cells, HL and phage,
V , are studied in the absence of a CRISPR system. In the second model, a CRISPR system
is introduced; we consider CRISPR-immune host cells, CS, and lysogens with a CRISPR
system (but no phage-specific spacer) CL (Model 2). In the third model, CRISPR-immune
bacteria CS are considered along with lysogens without a CRISPR system. The first case of
Model 3 describes the biofilm in isolation whereas in the second case a constant population
of planktonic (free) lysogens HˆL in the environment may join the biofilm. The common
parameters of all three models are described as follows.
The bacterial populations are modelled as cell densities per unit area of biofilm, cells/cm2.
These populations can increase logistically with a maximum growth rate r, but are limited
by a fixed number of available attachment sites in the biofilm matrix, given by carrying
capacity K cells/cm2. The bacteria leave the biofilm with sloughing off rate η that may
differ for CRISPR and non-CRISPR bacteria. We assume that the virus is able to diffuse
fairly freely through biofilm channels, yielding mass action attachment kinetics. Thus, βHV
gives the number of adsorption events per unit time, and infected bacterial cells typically
undergo lysis, producing b daughter phage. The increase in the bacteriophage population is
regulated by the rate of phage dissolution, γ; it is assumed that this phage loss includes phage
particles diffusing from the biofilm. We also impose the standard assumption that the loss of
phage via productive infection, βHV is negligible compared to the overall clearance rate γV .
Using these parameters, three systems of ordinary differential equations (ODEs) are analysed
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below to predict which populations will persist at equilibrium for realistic parameter regimes.
L S L
Wild-Type 
Bacteria: H 
Lysogens
H 
CRISPR Immune 
Bacteria: C 
CRISPR 
Lysogens: C 
Model 1 Model 2 
Model 3 
Figure 1: Bacterial populations considered in the models. H represents the population of wild-type bacteria,
HL represents the population of bacteria with prophage (lysogens), CS is the population of bacteria with a
CRISPR-CAS system, CL are lysogens with a CRISPR-CAS system. The bacterial populations H and HL
are considered in Model 1, CS and CL in Model 2 and HL and CS in Model 3.
2.2 Model 1
The first model is comparatively simple and based on the classical phage-bacteria interaction
when there is no CRISPR system in the bacterial cells. Two bacterial populations are
considered, the wild-type H and lysogens HL, along with a phage population V . The phage
can attach to wildtype cells with adsorption rate β, affecting the host cell in one of two
possible ways: (1) host cells H are lysogenized with probability pL, giving rise to lysogens
HL or (2) host cells are lysed with probability (1− pL) which results in the production of a
burst of b phage.
In lysogens, prophage induction is possible at rate α which again results in cell lysis with
burst size b. We assume lysogenization confers complete immunity to the virus, that is, HL
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cannot be infected. The model is represented by the following set of ODEs,
dH(t)
dt
= r
(
1− H +HL
K
)
H − βHV − ηH
dHL(t)
dt
= r
(
1− H +HL
K
)
HL + pLβHV − αHL − ηHL
dV (t)
dt
= b (1− pL) βHV − γV + bαHL
The purpose of this model is to study criteria for the stable existence of lysogens at equilib-
rium. This model clearly shows four steady states of which the first is the trivial equilibrium
(TE1), in which all populations are zero. This is possible when the sloughing off rate η is
sufficiently high to eradicate all bacteria from the biofilm. The second equilibrium is the
phage free equilibrium (PFE1) in which only wild-type bacteria survive, given by


H
HL
V


PFE1
=


K(r − η)
0
0

 (2)
Clearly the existence criterion for steady state PFE1 is η < r. The third equilibrium is the
lysogenic equilibrium (LE1) in which lysogens survive but the wild-type bacteria die out.
These lysogens produce prophage by induction which results in the survival of the phage
population. However, these phage have no effect on the bacterial population since lysogens
cannot be infected. The equilibrium LE1 is given by


H
HL
V


LE1
=


0
K r−(η+α)
r
Rα
r
(r − (η + α))

 (3)
where R
α
= Kbα/γ. The existence condition for LE1 is η < r− α (note that PFE1 also exists
when this condition holds). Finally, there is an all existing equilibrium (AEE1) in which all
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three populations are non-zero, given by,


H
HL
V


AEE1
=


V¯ KpL
R
β
(α−V¯ )(1−pL))
K
R
β
(1−pL)
KV¯
β

 (4)
where V¯ = (r − η)− r/Rβ and Rβ = Kbβγ . The existence condition for AEE1 is
r
(
1− 1
R
β
)
− α < η < r
(
1− 1
R
β
)
.
The eigenvalues of the Jacobian of each equilibrium provide stability conditions; these are
provided in detail in Appendix S1. We find that TE1 is only stable when r < η, that is, if
the sloughing off rate exceeds the maximum growth rate of the biofilm cells. For the local
stability of PFE1, the existence condition η < r ensures that the first eigenvalue is negative.
Considering the second eigenvalue, we find the stability condition η > r(1− 1/R
β
) for PFE1,
which holds when R
β
< 1. R
β
is analogous to a basic reproductive ratio for the phage, and
this result implies that when R
β
< 1, the disease-free state PFE1 is stable.
The stability conditions for LE1 are closely related to the conditions for PFE1 with an
additional dependence on the phage induction rate α; the condition for LE1 stability is
η < r(1 − 1/R
β
) − α. If we consider α to be sufficiently small, then stability switches
between LE1 and PFE1 at η = r(1 − 1/Rβ). Moreover, we see that Rβ > 1 must hold for
the stability of LE1. The eigenvalues of the Jacobian evaluated at AEE1 are complicated
analytical expressions, however, stability will be explored numerically in the next section.
The existence and stability criteria for each steady state in Model 1 are summarized in Table
2.
We note that, for biologically realistic parameter regimes, the phage induction rate α is
likely to be very small relative to r and η. Thus, AEE1 rarely exists, the existence criteria
for PFE1 and LE1 are effectively identical, and their stability criteria are complementary.
The population can stably exist in three states: if η > r the host cell population is not
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Table 2: Existence and stability conditions for the steady states in Model 1.
The abbreviations used in this table are R
β
= Kbβ
γ
, TE1: Trivial equilibrium,
PFE1: Phage free equilibrium, LE1: Lysogenic equilibrium, AEE1: all existing
equilibrium.
Steady State Existence Criteria Stability Criteria
TE1 − η > r
PFE1 η < r η > r(1− 1R
β
)
LE1 η < r − α η < r(1− 1R
β
)− α
AEE1 r
(
1− 1
R
β
)
− α < η < r
(
1− 1
R
β
)
evaluated numerically
sustainable and the trivial equilibrium is stable. If η < r, the stability criterion for PFE1
determines whether the phage-free or lysogenic equilibrium is stable. In agreement with
intuition, the PFE1 will be stable for Rβ < 1.
2.3 Model 2
In this model, we examine how the situation above might differ if the bacterial strains
involved have CRISPR immunity. We thus assume that both the wild-type and lysogenized
cells have a CRISPR-CAS system, and denote these populations CS and CL respectively.
The first population is assumed to have previously acquired the protospacer of phage DNA;
these CS cells are therefore CRISPR-immune. CRISPR-immune bacteria have the ability
to resist future infections by the same phage, however there is a small possibility of failure.
Therefore, in the case of phage adsorption by CS, the probability of CRISPR failure pF leads
the cell to lysis.
For lysogens with a CRISPR system, we note results from a recent experimental study [19]
which demonstrates that bacteriophage infection of previously lysogenized bacteria may lead
to cell death, if the CRISPR-CAS proteins acquire the protospacer of the infecting phage. In
this case, the same adsorption rate (β) is considered for the interaction between the bacterio-
phage V and lysogens CL, however this interaction is lethal to the cell with probability pD .
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Finally, lysogens have a CRISPR-CAS system which regulates their group behaviour [29] so
that they lose the expression of polysaccharides essential for biofilm formation. Therefore,
the sloughing off rate in CL increases (ηL > η). This dynamical system can be written as
dCS(t)
dt
= r
(
1− CS + CL
K
)
CS − pFβCSV − ηCS
dCL(t)
dt
= r
(
1− CS + CL
K
)
CL − pDβCLV − αCL − ηLCL
dV (t)
dt
= bpFβCSV − γV + bαCL
(5)
We begin by examining the existence conditions for equilibria of this model. Apart from
the trivial equilibrium (TE2 = (0, 0, 0)), there are four more equilibrium states: the phage
free equilibrium (PFE2) in which only CS survives, the lysogenic equilibrium (LE2) in which
CL and V survive, the CRISPR equilibrium (CE2) in which CS and V survive and the all
existing equilibrium (AEE2) in which all three populations exist. The first three non-trivial
equilibria can be written as:


CS
CL
V

 =


K(r−η)
r
0
0


PFE2
,


0
K r−(ηL+α)
R
β
αpD+r
R
α
r−(ηL+α)
R
β
αpD+r


LE2
,


K
p
F
R
β
0
(r−η)− r
p
F
R
β
βp
F


CE2
. (6)
The existence conditions for the phage free and lysogenic equilibria are similar to those
obtained from the previous model and are provided in Table 3. The equilibrium state for
AEE2 is given by


CS
CL
V

 =


K
α(pD (r−η)−pF (r−(α+ηL)))+
r
R
β
(α+ηL−η)
r(pF (ηL−η)+αpD)
Kp
F
(α + ηL − η)
p
F
(
r
(
1− 1
R
β
p
F
)
−(α+ηL)
)
−p
D
(
r
(
1− 1
R
β
p
F
)
−η
)
r(pF−pD)(pF (ηL−η)+αpD)
α+ηL−η
β(pF−pD)


AEE2
(7)
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The existence conditions for the above equilibrium are quite complex as shown in Table 3,
however one necessary condition is p
F
> p
D
. Note that this is the only equilibrium whose
existence depends on the relation between the probabilities of CRISPR failure and cell death.
All these conditions admit the possibility of co-existence of equilibria and we thus consider
stability conditions from the eigenvalues of the Jacobian, as provided in Appendix S2. In
brief, for PFE2 we find an analogous condition to that found in previous model for PFE1;
in particular, PFE2 is locally stable under the condition η > r
(
1− 1
R
β
p
F
)
. For CE2, the
second and third eigenvalues are complex conjugates with negative real parts whenever CE2
exists, and we find a necessary condition for the negativity of the first eigenvalue. Similarly,
for LE2, the second and third eigenvalues are negative whenever the equilibrium exists but
we derive a condition for the negativity of the first eigenvalue. Finally, the eigenvalues for the
Jacobian matrix of AEE2 are sufficiently complicated expressions that we will use numerical
methods to assess stability. Table 3 shows a summary of existence and stability conditions
for Model 2.
Table 3: Existence and stability conditions of the steady states in Model 2. The abbreviations
used in this table are R
β
= Kbβ
γ
, TE2: Trivial equilibrium, PFE2: Phage free equilibrium, LE2:
Lysogenic equilibrium, CE2: CRISPR equilibrium and AEE2: All existing equilibrium.
Steady State Existence Criteria Stability Criteria
TE2 − η > r
PFE2 η < r η > r(1− 1R
β
p
F
)
LE2 η < ηL < r − α η > r − (r − (α + ηL))
R
β
αp
F
+r
R
β
αpD+r
CE2 η < r
(
1− 1
R
β
p
F
)
η < r
(
1− 1
R
β
p
F
)(
1− pF
p
D
)
+
p
F
p
D
(α + ηL)
AEE2 η < r − (r − (α + ηL))
R
β
αp
F
+r
R
β
αp
D
+r
η > r
(
1− 1
R
β
p
F
)(
1− pF
p
D
)
evaluated numerically
+
p
F
p
D
(α + ηL), pF > pD
We find that the conditions for the stable existence of the trivial and phage-free equilibria
are identical to those described for Model 1, with R
β
replaced by R
β
pF . Thus again if the
sloughing off rate exceeds the growth rate, the biofilm cannot sustain itself. If the biofilm can
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sustain itself, we find that the phage population cannot be sustained if R
β
pF < 1. If both
the bacterial cells and phage are sustainable, however, three equilibrium states are possible.
Once again, though, we note that α is very small, and thus the lysogenic equilibrium is rarely
stable, since η < ηL by definition. The all existing equilibrium again has a possibly narrow
parameter range for existence, and thus the model predicts that for biologically relevant
parameter values, the CRISPR equilibrium is most likely to be observed. This is illustrated
further in the numerical work to follow.
2.4 Model 3
This model consists of a population of CRISPR-immune bacteria CS along with non-CRISPR
lysogens HL which continually contribute to the phage population V in the biofilm via
induction. The populations and parameters are the same as described for the previous
models, with the exception of the biofilm formation rate φ. The idea here is to study the
impact of a population of non-CRISPR lysogens HL on the population of CRISPR-immune
bacteria CS. This would allow us to investigate the possibility of using lysogens to deliver
phage therapy, with the long-term goal of eradicating the CRISPR-immune bacteria.
Since the lysogens HL do not have a CRISPR-CAS system, it is possible for planktonic
lysogens to express polysaccharides and join the outer layer of the biofilm. The model
assumes that planktonic bacteria are present in the environment around the biofilm, allowing
planktonic bacteria to form biofilm at a specific rate constant of adhesion while the medium
carrying planktonic bacteria flows into and out of the system, including the sloughed off
bacteria from the biofilm. We use φ to denote the maximum rate of biofilm formation by
planktonic bacteria; this rate is reduced by the carrying capacity such that the net biofilm
formation rate depends on the attachment sites available in the biofilm. We assume that
bacteria are lost from the biofilm independent of the density of planktonic bacteria; this
sloughing off rate is assumed to be the same for both CS and HL. The model is represented
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by the following equations,
dCS(t)
dt
= r
(
1− CS +HL
K
)
CS − pFβCSV − ηCS
dHL(t)
dt
=
(
1− CS +HL
K
)
(rHL + φ)− αHL − ηHL
dV (t)
dt
= bpFβCSV − γV + bαHL
(8)
The above system is studied in two cases: (1) when there are no planktonic lysogens in the
environment (φ = 0) and (2) when there are lysogens in the environment that may join the
biofilm (φ > 0).
Case (a): φ = 0
When the biofilm formation term φ = 0, this model becomes relatively simple, yielding
four steady states, three of which are defined in the previous model, i.e. the phage-free
equilibrium (PFE3), trivial equilibrium (TE3) and CRISPR equilibrium (CE3) with the
population of lysogens HL in place of CL, while the fourth equilibrium, i.e. the lysogenic
LE3, is as defined for LE1 with CS = 0 instead of H = 0.
The eigenvalues of the Jacobian evaluated at these equilibria are given in Appendix S3, and
the existence and stability conditions are summarized in Table 4. There are similarities in the
stability conditions of each equilibrium of this model with those described for the previous
models. In particular the stability conditions for the trivial and phage-free equilibria are
the same as previously described for Model 2. In this case since α is small, the CRISPR
equilibrium has a narrow range of stability, and biofilms are thus most likely to exist either
at the phage-free or lysogenic equilibria.
15
2.4.1 Case (b): φ > 0
This situation changes when planktonic lysogens in the environment are able to join the
biofilm. When φ > 0, only two equilibria remain. One is the lysogenic equilibrium (LEφ)
and the other is the all existing equilibrium (AEEφ). Equilibrium LEφ is given by:


CS
HL
V

 =


0
1
2r
(K(r − η − α)− φ+
√
(K(r − η − α)− φ)2 + 4Krφ))
R
β
2Kr
(K(r − η − α)− φ+
√
(K(r − η − α)− φ)2 + 4Krφ))


LEφ
, (9)
It can be observed that the lysogens and phage population are always positive because the
discriminant is always positive and greater than the expression outside the square-root.
For the stability of LEφ, a complex condition arises from the first eigenvalue, as given in
Appendix S3. However, the following condition is sufficient to ensure the stability of LEφ:
Kα(r − η) − ηφ < 0 which implies that φ > Kα(r−η)
η
. This condition is further analysed in
the numerical section to follow, in which the parameter space is explored to delineate the
region of stability.
The second equilibrium state AEEφ is given by:


CS
HL
V

 =


Kbα(r−η−D4βpF )−D4γr
br(α−D4βpF )
φ(η+βpFD4)
r(α−D4βpF )
D4


AEEφ
, (10)
where C4 = γr − bβpF (K(r − η) + φ) and D4 =
(−C4+
√
C2
4
+4Kb2β2ηp2
F
φ)
(2Kbβ2p2
F
)
. Since D4 is always
positive, we have two possible existence conditions:
(1) α−D4βpF > 0 =⇒ φ < Kα
(
1− r
α + η
(
1− Rβ
p
F
))
and
(2) Kbα (r − η −D4βpF )−D4γr > 0 =⇒ φ >
Kα (r − η)
(
r −R
β
p
F
(r − η − α)
)(
R
β
αp
F
+ r
) (
R
β
αp
F
+ η
) .
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Once again the eigenvalues of the Jacobian evaluated at AEEφ are not compact expressions,
and stability will be explored numerically in the next section.
Table 4: Existence and stability conditions of the steady states in Model 3. The abbreviations used
in this table are R
β
= Kbβ
γ
, TE3: Trivial equilibrium, PFE3: Phage free equilibrium, LE3 and LEφ:
Lysogenic equilibrium, CE3: CRISPR Equilibrium and AEE3 and AEEφ: All existing equilibrium.
Steady State Existence Criteria Stability Criteria
TE3 − η > r
PFE3 η < r η > r(1− 1R
β
p
F
)
LE3 η < r − α η < r(1− 1R
β
p
F
)− α
CE3 η < r
(
1− 1
R
β
p
F
)
r
(
1− 1
p
F
R
β
)
− α < η < r
(
1− 1
p
F
R
β
)
LEφ − φ > Kα(r−η)η (sufficient condition)
AEEφ φ >
αγK(r−η)(γr−Kbβp
F
(r−η−α))
(KbαβpF+γr)(KbαβpF+ηγ)
φ < Kα
(
1− r
α+η
(
1− γ
Kbβp
F
))
evaluated numerically
Model 3 has been developed to investigate the possibility of using lysogenized bacteria as a
delivery mechanism in phage therapy. Without the addition of lysogenized bacteria (φ = 0),
the most likely stable equilibrium for the realistic parameter values is PFE3, particularly
when R
β
< 1
p
F
; this corresponds to a biofilm composed of bacteria that are immune to the
phage. However the stability conditions for the two equilibria when φ > 0 imply that when
the rate of biofilm formation by lysogenized bacteria is sufficiently high, the population of
CRISPR-immune bacteria may be eliminated from the biofilm.
3 Numerical Simulations
Numerical simulations for the above models have been performed to illustrate the impact
of parameter values on the existence and stability of the steady states. In addition, the
eigenvalues for the Jacobian at two all existing equilibria (AEE1 and AEEφ) which were not
provided analytically are illustrated numerically.
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3.1 Parameter values
Baseline parameters were obtained through a review of experimental results in the literature
as well as parameter values used in previous mathematical modeling studies (Table 2) [3, 14,
21, 32, 36, 38]. The rate of bacterial growth r = 1 hr−1 is the maximum growth rate [1, 14]
in the logistic growth term; growth slows at higher densities. The carrying capacity of the
bacterial population inside the biofilm is the total attachment sites available per unit area.
We take K = 5× 106 cells/cm2 as chosen by Freter [21] and followed by [6] and [40].
We assume lysogens leave the cell population by means of prophage induction at the rate
α = 10−5 hr−1, producing b = 200 phage copies per cell through lysis. Phage can infect
bacteria at the rate β = 10−7 cm2 phage−1 hr−1 and produce b = 200 phage copies per cell
with probability 1 − pL, where pL = 0.05 is the probability of bacteria gaining prophage.
The phage loss rate is assumed to be γ = 0.05 hr−1 which includes phage dissolution and
sloughing off from the biofilm.
Biofilm formation and sloughing off are frequently discussed in the literature [6, 21, 40]. In
this article, the sloughing off rate of bacteria is the same in all models, except that lysogens
in Model 2, CL, leave the biofilm more rapidly due to the CRISPR response. The baseline
parameter value for the sloughing off rate for wildtype bacteria is taken to be η = 0.1
hr−1 and for lysogens with a CRISPR system is given by ηL =
√
η so that ηL > η when
0 < η < 1. The parameter value for the biofilm formation rate φ is found from Freter’s model
by assuming that the density of bacteria present near the biofilm is constant as K2 = 10
8
cells⁄cm3. The adhesion rate given in Freter’s model, i.e. θ˜ = 10−5 m3/hr/gram, is converted
to θ = θ˜K2 hr
−1 ≈ 5.56 × 10−7/hr by assuming that 1 gram of bacterial mass can contain
N = 1.8 × 1012 cells at maximum. Therefore, the population forming biofilm per hour is
given by φ = θK cells/cm2/hr, where K is the carrying capacity of the biofilm.
The CRISPR-CAS effects on the wild-type bacteria and lysogens are parametrised so that
they reflect biologically plausible dynamics. Since CRISPR immunity is considered highly
efficient with a small probability of failure, we take pF = 10
−4 [14]. The probability of
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failure is a key measure in the models, allowing us to study phage infection in CRISPR-CAS
bacteria. Failure is possible since the diversity in CRISPR arrays alters the effectiveness of
the CRISPR-CAS system. In particular, CRISPR spacers may become less effective over time
and therefore older spacers are preferentially replaced [52, 25]. The probability of death pD
depends on the adsorption rate of lysogens in the presence of CRISPR-CAS, the presence of
repressors for the phage and the diversity of CAS proteins inside CRISPR-immune bacteria.
In this study, the same adsorption rate is assumed for lysogens and non-lysogens, while
pD = 0.1 is used to model CRISPR-CAS initiated cell death.
Table 5: Baseline values for the parameters used in this study
Parameters values Source
K 5 × 106 cells cm−2 [21, 6, 40]
α 10−5 hr−1 [36, 13]
r 1 hr−1 [1]
b 200 phage cell−1 [1]
β 10−7 cm2 phage−1 hr−1 [1]
γ 0.05 hr−1 [1]
η 0.1 hr−1 [21]
ηL
√
η hr−1 −
φ 2.78 cells cm−2 hr−1 see text
pF 10
−4 [14]
pL 0.05 −
pD 0.1 −
3.2 Baseline analysis
In Figure 2, the population dynamics of each of these models are illustrated for the same
baseline parameter values and initial conditions. The simulations are run over long times to
illustrate stable equilibrium states, and in each case the numerical results were validated by
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comparison with the analytical expressions. We plot both population densities and time on
a log axis, such that initial transients are visible.
In the first model, the baseline scenario produces a stable lysogenic equilibrium (without
CRISPR), in which the phage population is maintained in the biofilm through induction.
This is a classical model which supports the idea of co-existence of temperate phage and
their bacterial hosts. This result should generalize to the case of many phage types, since
bacteria are capable of carrying several prophage as part of their genome.
In the second model, the CRISPR bacteria CS clearly dominate, since CRISPR immunity
makes these cells resistant to the phage. The CRISPR effects on the lysogens CL, i.e. the
death of lysogens or increase in the sloughing-off rate, make it possible to eliminate these
infected bacteria from the biofilm; their loss is followed by the loss of the phage population.
The second model demonstrates that CRISPR systems will disrupt the coexistence observed
in Model 1, and predicts that for bacteria with CRISPR systems, stable biofilms are likely
to be composed of CRISPR-immune bacteria only.
The populations in the first two models reach stable equilibria fairly quickly, whereas sim-
ulation results for the third model show that the populations take longer to reach their
stable states. In the absence of an external source of lysogens (Model 3a), CRISPR-immune
bacteria dominate, since the CRISPR system helps the bacteria to maintain the phage-free
equilibrium after eliminating non-CRISPR lysogens from the biofilm. When the external
source of lysogens is present (Model 3b), we observe stability of the all existing equilibrium
for these baseline parameter values. This is because a high biofilm formation rate is required
to meet the sufficient condition for the stability of LEφ, thus eliminating the CRISPR cells
from the biofilm. To investigate this further, we turn to parametric analysis to explore sce-
narios in which lysogens are able to replace CRISPR-immune bacteria in the biofilm. The
second goal of the parametric analysis is to find a suitable conditions at which, after the erad-
ication of CRISPR bacteria from the biofilm, the lysogens themselves could be eradicated.
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Figure 2: Dynamics of phage and bacterial populations inside the biofilm at baseline parametric values. H
and CS represent populations of wild-type bacteria and CRISPR-immune bacteria (dashed lines), CL andHL
represent lysogens with and without CRISPR systems (dots) and V is the population of bacteriophage (solid
lines). Model 1 approaches the lysogenic equilibrium LE1, Model 2 and Model 3 (case (a)) approach the
phage-free equilibria (PFE2 and PFE3) whereas Model 3 (case (b)) approaches the all existing equilibrium
(AEEφ).
3.3 Parametric analysis
In this section we illustrate several bifurcations that may occur in biologically realistic pa-
rameter regimes. We first illustrate the changes in equilibria and stability that result from
variation in the adsorption rate, β. Variation in the prophage induction rate, α, phage loss
rate, γ, and sloughing off rate η have similar qualitative effects and are shown in Appendix
S4. Finally, we examine the interesting case of variation in the biofilm formation rate, φ.
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Adsorption rate β
Variation in the adsorption rate constant affects the stability of equilibrium states by varying
R
β
. Figure 3 shows that LE1 remains stable for a wide range of β values in Model 1, while the
other models each switch stability between two equilibrium states at high rates of adsorption.
In Model 2, PFE2 is replaced by CE2 at high adsorption rates. This is due to the strong
immune response of CRISPR bacteria, such that even for high adsorption rates CRISPR-
immune bacteria survive, co-existing with the phage.
In Model 3, LE2 is stable at high β, replacing PFE3 in case (a) and AEEφ in case (b). We
note that the biofilm formation rate φ does not have a strong influence here, since almost
same adsorption rate β is required in both cases to eradicate CRISPR-immune bacteria.
Qualitatively, these results demonstrate that for biofilms without CRISPR systems (Model
1), lysogens and phage are predicted to coexist over a wide parameter range. In contrast,
for biofilms with CRISPR (Model 2), the stable equilibrium state is typically dominated by
CRISPR-immune bacteria. If CRISPR-capable lysogens are replaced by lysogens without a
functioning CRISPR system (Model 3, a and b), again CRISPR-immune bacteria typically
dominate, although for parameter regimes that are extremely favourable to phage reproduc-
tion, the lysogenic equilibrium may be stable. As shown in Appendix S4, these qualitative
conclusions also hold for variations in parameters α, η and γ.
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Figure 3: Population densities of bacteria and bacteriophage at stable (solid lines) and unstable (dashed lines)
equilibrium states against adsorption rate constant β in the above models. Each colour represents a unique
population while the line width is increased to visualize overlapping populations. Bacterial populations are
H (green) and HL (blue) in Model 1, CS (black) and CL (purple) in Model 2 and CS and HL in Model 3
whereas the phage population is represented by V (red) in all models.
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Biofilm formation rate φ
In Model 3, the rate of biofilm formation by planktonic lysogens is an important parameter
that can be regulated either by increasing the density of lysogens near the biofilm or by
increasing the adhesion rate. We illustrate the effect of varying this parameter in panel
(a) of Figure 4. As the value φ increases, the lysogen population increases along with the
phage, while the population of CRISPR-immune bacteria CS decreases in the biofilm, and is
eventually eliminated at high values of φ. Though a relatively large formation rate is required
to eliminate CS, this threshold value depends on other model parameters. In particular, the
critical φ value to ensure the stability of the lysogenic equilibrium in Model 3 (case (b)) is
give by φ > Kα (r−η)
η
. In the lower three panels of Figure 4 we plot this threshold against
α, η and the carrying capacity K. Clearly, an increase in the value of α and K require an
increase in the value of φ to make the lysogenic equilibrium stable, whereas an increase in
the sloughing off rate η reduces the threshold value of φ.
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Figure 4: (a) Population densities of bacteria and bacteriophage at stable (solid lines) and unstable (dashed
lines) equilibrium states against phage loss rate constant γ in the Model 3 (case (b)). Bacterial populations
CS (black) and HL (blue) and the phage population V (red) are shown. Panels (b), (c) and (d) show the
critical value of φ necessary to ensure the stability of the lysogenic equilibrium, versus α, η and K. In each
case, the parameter space above each curve corresponds to a stable lysogenic equilibrium (LEφ) while the
space under each curve corresponds to stability of the all existing equilibrium (AEEφ).
4 Discussion
We explore the dynamics of lysogenic phage in a bacterial biofilm, for bacterial hosts both
with and without CRISPR immunity. Classical models of phage-bacteria interactions have
previously demonstrated that lysogeny can promote the stable co-existence of bacteria and
phage [13]. In agreement with these findings, Model 1 explores the baseline conditions under
which lysogeny exists in a biofilm, and provides conditions for the stability of a lysogenic
equilibrium. The second and third models demonstrate the powerful effect of the CRISPR-
CAS system in comparison with the non-CRISPR bacterial population in the first model.
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The second model predicts that at realistic parameter values, only prophage-free CRISPR-
immune bacteria stably survive in a bacterial biofilm. In rare cases, the CRISPR system
stably co-exists with the phage, however the CRISPR system does not allow lysogens to
co-exist at this equilibrium. In the third model, there is no CRISPR system present in
the lysogens. In the absence of an external source of lysogens (case (a)), CRISPR-immune
bacteria are predicted to dominate the biofilm. However if an external source of planktonic
lysogens contributes to the biofilm, CRISPR bacteria may co-exist with lysogens or can even
be eliminated from the biofilm. This last result is of clinical relevance because CRISPR
bacteria are highly resistant to phage therapy. Once CRISPR bacteria are removed from the
biofilm, phage therapy has a much higher chance of success.
The existence and stability conditions were found analytically to define the parametric re-
gions in which populations exist or remain stable. In order to visualize the population
behaviour in the biologically meaningful parameter space, computer simulations were used
to verify the stability conditions. In addition, parametric analysis was used to explore real-
istic parameter regimes, and to define therapeutic strategies to eradicate CRISPR-immune
bacteria from the biofilm. These results indicate that large magnitude changes in any one
baseline parameter value would be required to achieve that objective. This suggests that
means of varying several parameters simultaneously might hold more therapeutic promise.
In the first model, the lysogenic equilibrium is typically stable for realistic parameter values.
This equilibrium (LE1) loses stability when β <
γr
Kb(r−η−α)
. If we consider the sloughing
off rate η and prophage induction rate α to be negligible compared to the growth rate r,
then this condition reduces to β < γ
Kb
or R
β
< 1 which ensures the stability of PFE1. In
between the regions of stability of LE1 and PFE1, there is a small region of length α where
AEE1 exists. Although the biological relevance of this region is arguable, we provide some
numerical explorations in Figure S1.
The second model predicts that the CRISPR response is sufficiently strong to eliminate
lysogens, and therefore CRISPR-immune bacteria dominate the biofilm over a wide range of
parameter values. At high infection rates (i.e. β > γ
KbpF
), assuming the sloughing off rate is
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negligible compared to the bacterial growth rate, a stable CRISPR equilibrium CE2 exists.
This predicts that the phage may exist at high adsorption rates, while lysogen survival is
unlikely unless the death probability pD goes to zero and sloughing off rates ηL and η become
equal. These two conditions would only hold in the unlikely scenario that the CRISPR system
has no effect on the lysogens.
The third model explored the case of non-CRISPR lysogens and CRISPR-immune non-
lysogens. At baseline parametric values, the lysogens are predicted to go extinct, while the
CRISPR-immune bacteria stably exist inside the biofilm. In some more extreme parameter
regimes, lysogens also persist at equilibrium. The corresponding eigenvalues show that the
stability of LE3 and PFE3 have almost complementary conditions, although a small region
of bi-stability exists, i.e. r − η < γr
Kbβp
F
< r − η − α.
Case (b) of Model 3 was specifically designed to explore the possibility of using lysogens
to penetrate the biofilm and reduce the population of CRISPR-immune bacteria. A high
rate of biofilm formation is necessary to eliminate CRISPR-immune bacteria CS in this
case; both lysogens and phage are always present in the biofilm because of their continuous
influx through flow. Although our model treats only one type of virus and corresponding
prophage, an interesting possibility here is that diverse prophage could be introduced via
the lysogens joining the biofilm. In this way, lysogens could produce a number of different
viruses via induction, and this could ultimately reduce the entire biofilm population. Since
older CRISPR spacers in the bacteria become less efficient, the possibility of CRISPR failure
increases with phage diversity, which helps to eradicate CRISPR-immune bacteria CS. Once
CRISPR bacteria have been eliminated, the biofilm can be treated by classical therapeutic
techniques.
Although the arguments above are highly speculative, the main results of our research are
summarized in Figure 5 which is divided into four panels (vertical lines). On the left, we
use Model 2 to simulate a pathogenic biofilm that is resistant to phage therapy because it
consists entirely of CRISPR-immune bacteria. In the second panel, an external, possibly
therapeutic source of planktonic lysogens is applied, and the all existing equilibrium state
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emerges. When the concentration of lysogens in the external source is further increased
(3rd panel), the CRISPR-immune bacteria are eradicated from the biofilm and the model
shows the same behaviour as Model 1 with only lysogens and phage surviving. At realistic
baseline parameters, the lysogenic equilibrium emerges. Once the CRISPR population has
been eliminated, the external source of lysogens can be removed and Models 3 and 1 are
equivalent. Variations in a number of parameter values can then be used to eliminate the
lysogens (panel 4). For example, as mentioned above, diversity in the prophages carried
by lysogens could produce a number of distinct phage populations inside the biofilm, which
could infect bacteria and also increase the prophage induction rate. Extending the analysis
presented here to include multiple phage types is an intriguing possibility for future work.
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Figure 5: Population dynamics of phage-bacteria interaction in Models 2, 3 (case (b)) and 1. Three Vertical
lines are drawn to separate the simulations of the models into four panels. Model 2 is simulated for baseline
parameters in the first panel, Model 3 (case (b)) is first simulated for baseline parameters and then simulated
after an increase in φ in the second and third panels respectively. In the fourth panel, simulations of Model 1
are presented for baseline parameters (top two curves) and for varied parameters based on possible therapy,
i.e. η = 0.45, α = 0.3 and r = 0.75, (bottom two curves with increased line-width). The dashed lines
represent CS , dash-dot lines represent CL in Model 2, and HL in Model 1 and 3, whereas dots symbolize
the population density of phage V .
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Appendices
S1 Eigenvalues of the Equilibrium States in Model 1
The Jacobian of Model 1, evaluated at PFE1 provides the following eigenvalues
λPFE1 =


−(r − η)
−α + 1
2r
(
A1 +
√
A21 + 4Kbβr(r − η)αpL
)
−α + 1
2r
(
A1 −
√
A21 + 4Kbβr(r − η)αpL
)

 , (11)
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where A1 = Kbβ(1 − pL)(r − η) − r(γ − α). Clearly, all eigenvalues are real which implies
that there can be no oscillation. Furthermore, the first and the third eigenvalues are always
negative for η < r. Conditions for negativity of the second eigenvalue are discussed in the
main text.
The eigenvalues of the Jacobian evaluated at the lysogenic equilibrium LE1 are
λLE1 =


−(r − (η + α))
α
(
1− Rβ
r
(r − (η + α))
)
−γ

 (12)
where R
β
= Kbβ
γ
. When the prophage induction rate is high (e.g. α = 0.1), a narrow range of
parameter space allows for the stable existence of AEE1. Although the biological relevance
of this regime is limited, a brief numerical exploration reveals that a stable limit cycle, stable
node, or instability are all possible, depending on the initial conditions and the sloughing off
rate η (see Figure S1).
S2 Eigenvalues of the Equilibrium States in Model 2
The eigenvalues of the Jacobian for Model 2, evaluated at PFE2 are:
λPFE2 =


−(α + ηL − η)
−(r − η)
R
β
p
F
(r−η)−r
γr

 (13)
The Jacobian evaluated at CE2 provides the following eigenvalues:
λCE2 =


r
(
1− 1
R
β
p
F
)(
1− pD
p
F
)
− (α + ηL) + η
(
p
D
p
F
)
−1
2
(
r
R
β
p
F
+
√(
r
R
β
p
F
)2
− 4γ
(
r
(
1− 1
R
β
p
F
)
− η
))
−1
2
(
r
R
β
p
F
−
√(
r
R
β
p
F
)2
− 4γ
(
r
(
1− 1
R
β
p
F
)
− η
))


(14)
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Figure S1: Stable and unstable all existing equilibrium at specific parameter values: α = 0.1, p
L
= 0.1 and
γ = 0.1 in Model 1. Bacterial population H and population of virions V are shown in this figure. At η = 0.9,
AEE1 shows either a stable equilibrium state (approached by the dashed trajectory in the centre of the
figure) or a stable limit cycle (dots, trajectories spiraling outward), whereas at η = 0.93, AEE1 is unstable
(dashed-dot line). Each small circle represents the beginning of the curve whereas the arrows represent the
direction of the curves.
Since η < r
(
1− 1
p
F
R
β
)
from the existence condition, the sufficient condition for the negativ-
ity of the first eigenvalue is
p
D
p
F
≥ 1, whereas the other two eigenvalues are always negative.
Evaluating the Jacobian at the lysogenic equilibrium LE2 provides the following eigenvalues,
λLE2 =


Kbαβ(pD (r−η)−pF B2)+γr(α+ηL−η)
A2
−γ(A2+rB2)+
√
γ2(A2−rB2)2−4KbαβpDγA2B2
2A2
−γ(A2+rB2)−
√
γ2(A2−rB2)2−4KbαβpDγA2B2
2A2

 , (15)
where A2 = KbαβpD + γr and B2 = r − (α + ηL). The last two eigenvalues for LE2 are
always negative while the first one requires a condition that is provided in Table 3.
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S3 Eigenvalues of the Equilibrium States in Model 3
Eigenvalues for the Jacobian of Model 3, evaluated at the CRISPR equilibrium CE3 are
given by:
λCE3 =
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(16)
The eigenvalues for the Jacobian of LE3 are given by:
λLE3 =


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−(r − (η + α))
−αRβ pF
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(
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)
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)
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The eigenvalues for the lysogenic equilibrium LEφ are found to be
λLEφ =


R
β
αp
F
2Kr
(
A4 −
√
A24 + 4K (η + α)
)
+ 1
2
B4−
√
B2
4
−4K(Kα(r−η)−ηφ)
K
−
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4
+4K(η+α)φ
K
−γ

 , (18)
where A4 = −K (r − (η + α)) + φ and B4 = K (r + α− η) + φ. The stability conditions for
the lysogenic equilibrium LEφ in terms of sloughing off rate η are:
η >
1
KC4

B4 +KrC4 − 1
2
B4
(
B4 −
√
B24 − 4RβαpF (r +KφC24)
)
R
β
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
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2
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)
R
β
αp
F

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(19)
where B4 = r +RβαpF and C4 =
r−RβαpF
(Kα+φ)
.
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S4 Supplementary Section: Parameter values
Prophage induction rate α
The induction rate was varied to investigate its effectiveness against the CRISPR and non-
CRISPR lysogens in the biofilm (see Figure S2). In the case of competition between non-
CRISPR bacterial populations, i.e. Model 1, variations in α had no effect; the lysogenic
equilibrium remains stable. Likewise, in the presence of a CRISPR system, Model 2, lysogens
die out due to the death and sloughing off rates regardless of the value of α; this result holds
for Model 3a as well.
In case (b) of Model 3, we see that at low rates of prophage induction, i.e. α < ηφ/K(r − η),
the lysogenic equilibrium is stable. As the lysogen lifetime is reduced due to increases in
prophage induction, the population of CRISPR-immune bacteria also emerges.
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Figure S2: Population densities of bacteria and bacteriophage at stable (solid lines) and unstable (dashed
lines) equilibrium states against prophage induction rate constant α in the above models. Each colour
represents a unique population while the line width is increased to visualize the overlapping behaviours of
populations. Bacterial populations are H (green) and HL (blue) in Model 1, CS (black) and CL (purple) in
Model 2 and CS and HL in Model 3. The phage population is represented by V (red).
Rate of Phage loss γ
For the non-CRISPR populations, Model 1, the lysogenic equilibrium is stable at all bio-
logically meaningful values for the rate of phage loss, as shown in Figure S3 (top-left plot),
and the all existing equilibrium is never stable, even at very high rates of γ. On the other
hand, CRISPR immunity makes it possible for non-lysogens to stably exist at most plausible
values of γ, although for very low γ the CRISPR equilibrium (CE2) is stable in Model 2. In
Model 3a, CRISPR bacteria again dominate most of the parameter space (see Figure S3).
In case (b) of Model 3, the external lysogens joining the biofilm do not stabilize LEφ sig-
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nificantly; the lysogenic equilibrium is only stable for γ < 0.01. For most values of γ, the
lysogens exist along with a population of CRISPR-immune bacteria and a decreasing density
of phage in the biofilm, which is an obvious consequence of increasing phage loss.
Phage loss rate constant γ
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Figure S3: Population densities of bacteria and bacteriophage at stable (solid lines) and unstable (dashed
lines) equilibrium states against phage loss rate constant γ in the above models. Each colour represents a
unique population while the line width is increased to visualize the overlapping behaviours of populations.
Bacterial populations are H (green) and HL (blue) in Model 1, CS (black) and CL (purple) in Model 2 and
CS and HL in Model 3. The phage population is represented by V (red).
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Sloughing off rate η
The sloughing off rate is an important parameter in analyzing the stability of each model
since it weakens the bacterial population by increasing its rate of loss from the biofilm.
The stability of the steady states are very similar to those observed in the above parameter
analyses. In general, we see that an increase in the sloughing off rate η reduces the population
of bacteria and phage in the biofilm, leading at very high rates to the trivial equilibrium
(TE). This is because when η approaches r, all the populations go extinct as shown in Figure
S4.
The sloughing off rate η affects lysogens either at the same rate as CRISPR-immune bacteria
(Model 3a) or at the higher rate (Model 2). Moreover, in case (b) of Model 3, it can be
observed that CRISPR-immune bacteria are eliminated from the biofilm before η reaches
r = 1, while the lysogens persist because the planktonic lysogens are continuously joining the
biofilm. Since there are only two steady states in this case, the parametric value satisfying
η > Kαr/Kα+ φ is sufficient to eradicate the CRISPR-immune bacteria from the biofilm.
Among the parameters involved in the inequality, φ seems to be an important parameter
which can be increased to eradicate CS even at comparatively low values of η.
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Sloughing off rate constant η
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Figure S4: Population densities of bacteria and bacteriophage at stable (solid lines) and unstable (dashed
lines) equilibrium states against sloughing off rate constant η in the above models. Each colour represents
a unique population while the line width is increased to visualize their overlapping behaviours. Bacterial
populations are H (green) and HL (blue) in Model 1, CS (black) and CL (purple) in Model 2 and CS and
HL in Model 3. The phage population is represented by V (red).
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